1 IN THE NAME OF GOD. 2 OSTEOARTHRITIS 3 EPIDEMIOLOGY.
-
Upload
erick-williams -
Category
Documents
-
view
214 -
download
0
Transcript of 1 IN THE NAME OF GOD. 2 OSTEOARTHRITIS 3 EPIDEMIOLOGY.
4
EPIDEMIOLOGYEPIDEMIOLOGY
Most common type of arthritisMost common type of arthritis
A leading cause of disability in elderlyA leading cause of disability in elderly
Prevalence:Prevalence:
-- Aging Aging
-- Obesity Obesity
5
EPIDEMIOLOGYEPIDEMIOLOGY
Common in:Common in:Knee, hand, spine…Knee, hand, spine…
Spared:Spared:Wrist, elbow, shoulder, ankleWrist, elbow, shoulder, ankle
Symptomatic knee OA:Symptomatic knee OA:>30y 6%>30y 6%
>60y 12%>60y 12%
6
EPIDEMIOLOGYEPIDEMIOLOGY
Symptomatic hand OA:Symptomatic hand OA:10% of elderly10% of elderlyHand OA >50% of person >70yHand OA >50% of person >70y
Correlate strikingly with age:Correlate strikingly with age: -- <40y Uncommon <40y Uncommon
Sex:Sex:More common in womenMore common in women Sex differences with ageSex differences with age
8
PROTECTORSPROTECTORS
Capsule and ligaments:Capsule and ligaments:Limits excursion Limits excursion
Muscles and tendons:Muscles and tendons:Key protectorKey protector
Function:Function:
- - Appropriate powerAppropriate power
-- Focal stress by: Focal stress by:
-- Decelerate joint Decelerate joint
-- Distribute across joint surface Distribute across joint surface
9
PROTECTORSPROTECTORS
Mechanoreceptor:Mechanoreceptor:In ligament, skin and tendonIn ligament, skin and tendon
Assume appropriate tensionAssume appropriate tension
Synovial fluid:Synovial fluid: FrictionFriction
Lubricin: secreted by fibroblasts Lubricin: secreted by fibroblasts Subchondral boneSubchondral bone
Shock-absorber Shock-absorber
10
PROTECTORSPROTECTORS
Cartilage:Cartilage:A thin rim of tissueA thin rim of tissue
Function:Function:
-- Frictionless surface Frictionless surface
-- Absorbing capacity Absorbing capacity
Component:Component:
-- Chondrocyte Chondrocyte
- - MatrixMatrix
11
PROTECTORSPROTECTORS
Chondrocyte:Chondrocyte:Synthesize all element of matrixSynthesize all element of matrix
Secret:Secret:
- - Growth factorsGrowth factors
- - Cytokines (MMP…)Cytokines (MMP…)
Matrix:Matrix:Type 2 collagen Tensile strengthType 2 collagen Tensile strength
Proteoglycans (aggrecan) Compressive strengthProteoglycans (aggrecan) Compressive strength
13
PATHOPHYSIOLOGYPATHOPHYSIOLOGY
Joint failureJoint failure
Initial step: failure of protective mechanismsInitial step: failure of protective mechanisms
Pathologic change in all structures of jointPathologic change in all structures of joint
Hallmark: hyaline cartilage lossHallmark: hyaline cartilage loss
14
PATHOPHYSIOLOGYPATHOPHYSIOLOGY
Chondrocytes:Chondrocytes: Metabolic activity, catabolic activity PGMetabolic activity, catabolic activity PG
Apoptosis Apoptosis
Chondrocytes and synovium:Chondrocytes and synovium:IL1IL1 and TNFaand TNFa
Chondrocyte
PROTEINASE
MATRIX SYNTHESIS
PG E2
NOPROTEINASE ACTIVITY
AGGRECAN SYNTHESIS
16
PATHOPHYSIOLOGYPATHOPHYSIOLOGY
OA cartilageOA cartilage
Aggrecan and CollagenAggrecan and Collagen
Compressive and Tensile strengthCompressive and Tensile strength
18
RISK FACTORSRISK FACTORS
AGE:AGE:Most potent Most potent Mechanisms:Mechanisms:
Matrix synthesis Thin cartilageMatrix synthesis Thin cartilage
Muscles:Muscles: -- Weaker Weaker - - Less quickly response Less quickly response
Slow sensory imputeSlow sensory impute
Ligament Ligament
19
RISK FACTORSRISK FACTORS
FEMALE FEMALE
GENETIC (OA in member):GENETIC (OA in member):Hand & Hip 50%Hand & Hip 50%
Knee 30%Knee 30%
Generalized Rare Generalized Rare
20
RISK FACTORSRISK FACTORS
JOINT:JOINT:
Developmental Developmental
FractureFracture
AVN (Avascular necrosis) AVN (Avascular necrosis)
Tear of ligamentTear of ligament
Menisc Menisc
Malalignment Malalignment
Bone densityBone density
21
RISK FACTORSRISK FACTORS
OBESITY:OBESITY:Knee in stance 3-6 times of weightKnee in stance 3-6 times of weight
Knee OA and less for hip and hand OAKnee OA and less for hip and hand OA
Women: Stronger (linear)Women: Stronger (linear)
SymptomSymptom
Mechanisms: Mechanisms: -- Loading Loading
-- Metabolic Metabolic
22
RISK FACTORSRISK FACTORS
REPEATED USE:REPEATED USE:Farmers: Hip Farmers: Hip
Miners: Knee and Spine Miners: Knee and Spine
Shipyards: Knee and FingerShipyards: Knee and Finger
Runners: HipRunners: Hip
Elite runner: Hip and Knee Elite runner: Hip and Knee
29
SOURSE OF PAINSOURSE OF PAIN
Cartilage AneuralCartilage Aneural
Innervated structures:Innervated structures:Synovium, Ligaments, Capsule, Muscle, Bone( Sub.)Synovium, Ligaments, Capsule, Muscle, Bone( Sub.)
NOT VISUALIZED BY X RAYNOT VISUALIZED BY X RAY
X RAY CHANGES AND PAIN SEVERITY X RAY CHANGES AND PAIN SEVERITY
POORLY POORLY CORRELATIONCORRELATION
31
CLINICAL FEATURESCLINICAL FEATURES
Mechanical painMechanical pain
Gelling painGelling pain
Night painNight pain
38
DIAGNOSISDIAGNOSIS
CLINICALCLINICAL
No blood test routinely indicatedNo blood test routinely indicated
Synovial fluidSynovial fluid
39
DIAGNOSISDIAGNOSIS
X Ray:X Ray:Hand and hip painHand and hip painknee if:knee if:
-- Not typical symptom Not typical symptom -- Pain persists after effective treatment Pain persists after effective treatment
Poorly correlation with pain severityPoorly correlation with pain severity
MRI:MRI: Not indicated Not indicated - - Meniscal tear in most patientsMeniscal tear in most patients
48
TREATMENTTREATMENT
NON PHARMACOTHERAPYNON PHARMACOTHERAPYMainstay of therapyMainstay of therapy
Weight loss: Weight loss:
-- Each Kg of weight: Load in knee 3-6 fold Each Kg of weight: Load in knee 3-6 fold
-- Symptom of Knee & Hip OA Symptom of Knee & Hip OA
49
TREATMENTTREATMENT
NON PHARMACOTHERAPYNON PHARMACOTHERAPYAvoiding overload the jointAvoiding overload the joint
-- Knee & Hip Cane in opposite hand Knee & Hip Cane in opposite hand
Exercise:Exercise:
-- Age Age
-- Disuse Disuse
-- Arthrogenous inhibition Arthrogenous inhibition
50
TREATMENTTREATMENT
NON PHARMACOTHERAPYNON PHARMACOTHERAPYDegree of weakness correlate strongly with:Degree of weakness correlate strongly with:
-- Severity of pain Severity of pain
-- Physical limitation Physical limitation
Correction of malalignment Correction of malalignment
51
TREATMENTTREATMENT
PHARMACOTHERAPYPHARMACOTHERAPYAcetaminophenAcetaminophen
NSAIDNSAID
Injection Injection